Neos Therapeutics Receivables

Neos Therapeutics (NEOS) currently reports a receivables of $20M as of September 2020. That compares with $29M in the prior-year period — down 29.4% year over year. Use the charts on this page to explore Neos Therapeutics's receivables history and peer comparisons.

Neos Therapeutics's receivables decreased from $29M to $20M — a 29.4% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neos Therapeutics reported $20M in receivables as of September 2020. That compares with $29M in the prior-year period — down 29.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neos Therapeutics, and consider following NEOS for alerts when major investors trade the stock.

Neos Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NEOS with unrelated industries.